PharmiWeb.com - Global Pharma News & Resources
30-Aug-2019

HumanOptics AG: Majority stake in HumanOptics AG to be sold to Chinese investor

HumanOptics AG / Key word(s): Miscellaneous
HumanOptics AG: Majority stake in HumanOptics AG to be sold to Chinese investor

30-Aug-2019 / 19:04 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Majority stake in HumanOptics AG to be sold to Chinese investor

Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.

Contact:
HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com


30-Aug-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: HumanOptics AG
Spardorfer Str. 150
91054 Erlangen
Germany
Phone: +49 (0)9131 - 50665-60
Fax: +49 (0)9131 - 50665-93
E-mail: mail@humanoptics.com
Internet: www.humanoptics.de
ISIN: DE000A1MMCR6
WKN: A1MMCR
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart
EQS News ID: 866581

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 30-Aug-2019